The acquisition will bring the Nasdaq-listed Theratechnologies back under privat...
The UK’s Labour Government has revealed its ’10-year plan’ for the country’s Nat...
BioVersys and Shionogi have entered a research and exclusive licence option agre...
Lynozyfic has the potential to be administered monthly, giving it an advantage o...
Data fragmentation slows operations, increases costs, and blocks the ability to ...
Modella AI has signed a multi-year agreement with AstraZeneca for expediting AI-...
The approval comes amid speculation that AstraZeneca CEO Pascal Soriot is consid...
More than half of the top 15 pharma companies are expected to face challenges in...
Biocon Biologics’ Denosumab biosimilars, Vevzuo and Evfraxy, have received marke...
Brii Biosciences and Joincare Pharmaceutical have signed a licence and technolog...
In a groundbreaking advancement in neurorehabilitation, researchers have unveile...
A groundbreaking new study has unveiled a complex genetic link that intertwines ...
In recent years, the integration of artificial intelligence and biomechanics has...
In an era where climate change dominates global discourse, understanding the nua...
In the vast, frozen realms of Earth’s coldest environments—ranging from the spra...
In a groundbreaking study poised to reshape our understanding of liver cancer me...
